...
首页> 外文期刊>Inhalation toxicology >Assessment of cyclohexanone toxicity in inhalation-exposed F344 rats and B6C3F1 mice: applications in occupational health
【24h】

Assessment of cyclohexanone toxicity in inhalation-exposed F344 rats and B6C3F1 mice: applications in occupational health

机译:在吸入暴露的F344大鼠和B6C3F1小鼠中评估环己酮毒性:职业健康的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cyclohexanone is a chemical used in various industries and many workers are exposed to it. Therefore, in this study, we determined the toxicity of cyclohexanone in inhalation-exposed F344 rats and B6C3F1 mice, so as to apply the findings in hazard and risk assessments. Methods: Ten male and 10 female rats and mice per test group were exposed to cyclohexanone vapors at 0, 100, 250, and 625 ppm concentrations for 6h per day, 5d per week, and for 13 weeks. All rats and mice were killed after the exposure period. Clinical signs, body weight, feed intake, and oph-thalmoscopy findings were recorded during the exposure period, and hematology, blood biochemistry, organ weights, gross findings, and histopathology were evaluated thereafter.Results: The following findings were noted in cyclohexanone-exposed F344 rats: increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, increased liver weight, and bile duct hyperplasia in the males exposed to 250 and 625 ppm cyclohexanone, increased ALT levels and bile duct hyperplasia in the females exposed to 625 ppm cyclohexanone, and increased blood urea nitrogen (BUN) and tubular basophilia in the renal cortex in the males exposed to 625 ppm cyclohexanone. On the other hand, B6C3F1 mice exposed to cyclohexanone showed no obvious exposure-related effects.Conclusion: Based on the findings, the no-observed-adverse-effect level (NOAEL) was determined to be 100 ppm in F344 rats and >625ppm in B6C3F1 mice. Therefore, 2 ppm was revealed as the derived no-effect level (DNEL) for cyclohexanone.
机译:背景:环己酮是各种行业中使用的化学品,许多工人都暴露在外。因此,在本研究中,我们确定了环己酮在吸入暴露的F344大鼠和B6C3F1小鼠中的毒性,从而在危险和风险评估中应用调查结果。方法:10个雄性和10只雌性大鼠和每次试验组的小鼠在0,100,250和625ppm浓度下暴露于每天6小时,每周5d,每周5d和13周。暴露期后,所有大鼠和小鼠都被杀死。在暴露期间记录临床症状,体重,饲料摄入和OPH-脑镜检查结果,以及血液学,血液化学,器官重量,总调查结果和组织病理学。结果:在环己酮暴露中注意到以下发现F344大鼠:丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平增加,肝脏重量增加,胆汁管道中暴露于250%和625ppm的雄性,增加的女性Alt水平和胆管增生暴露于625ppm环己酮和血尿尿素氮(BUN)和管状嗜碱性嗜碱性疗法在625ppm环己酮中暴露于625ppm的肾皮质中。另一方面,暴露于环己酮的B6C3F1小鼠没有明显的曝光相关的效果。结论:基于发现,在F344大鼠和> 625ppm中,确定无观察到的不利效应水平(NOAEL)为100ppm,> 625ppm B6C3F1小鼠。因此,揭示了2ppm作为环己酮的衍生的无效应水平(乳酸)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号